Related Experiment Video
Updated: Jun 26, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
No exit: targeting the budding process to inhibit filovirus replication
1Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA. rharty@vet.upenn.edu
Abstract:
The filoviruses, Ebola and Marburg, cause severe hemorrhagic fever in humans and nonhuman primates, with high mortality rates. Although the filovirus replication pathway is now understood in considerable detail, no antiviral drugs have yet been developed that directly inhibit steps in the replication cycle. One potential target is the filovirus VP40 matrix protein, the key viral protein that drives the budding process, in part by mediating specific virus-host interactions to facilitate the efficient release of virions from the infected cell. This review will summarize current knowledge of key structural and functional domains of VP40 believed to be necessary for efficient budding of virions and virus-like particles. A better understanding of the structure and function of these key regions of VP40 will be crucial, as they may represent novel and rational targets for inhibitors of filovirus egress.
Insights
Ebola and Marburg viruses cause deadly hemorrhagic fevers. Targeting the VP40 matrix protein, crucial for viral budding, offers a promising strategy for developing new filovirus antiviral drugs.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Filoviruses, including Ebola and Marburg, are significant public health threats causing severe hemorrhagic fevers.
- Despite detailed understanding of filovirus replication, no direct antiviral therapies exist.
- The VP40 matrix protein is essential for filovirus budding and virion release.
Purpose of the Study:
- To review current knowledge on the structural and functional domains of the filovirus VP40 matrix protein.
- To identify key regions of VP40 critical for efficient virion and virus-like particle budding.
- To highlight VP40 as a potential target for novel antiviral drug development.
Main Methods:
- Literature review of existing research on filovirus VP40 structure and function.
- Analysis of studies detailing VP40's role in virus-host interactions and virion egress.
- Synthesis of information on structural domains essential for budding efficiency.
Main Results:
- Identified key structural and functional domains within the VP40 matrix protein.
- Highlighted VP40's critical role in mediating virus-host interactions for efficient virion release.
- Emphasized the importance of VP40 in the budding process of filoviruses.
Conclusions:
- Understanding VP40's structure-function relationships is crucial for filovirus control.
- VP40 represents a rational and novel target for developing inhibitors of filovirus egress.
- Targeting VP40 could lead to the development of urgently needed antiviral therapies against filoviruses.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Viral Replication: Lytic Cycle

